Matrix Gelatinases in Atherosclerosis and Diabetic Nephropathy: Progress and Challenges

Author(s): Grigorios G. Dimas*, Triantafyllos P. Didangelos, Dimitrios M. Grekas

Journal Name: Current Vascular Pharmacology

Volume 15 , Issue 6 , 2017

Become EABM
Become Reviewer

Graphical Abstract:


Background: Matrix metalloproteinases (MMPs) are zinc-dependent proteases that degrade components of the extracellular matrix (ECM). In glomerular disease, MMPs are major regulators of ECM degradation as well as structural and functional integrity in the glomerulus. In altered matrix composition diseases, glomerular damage is due to increased degradation of kidney and vessel basement membranes (BMs) by MMPs. MMP -2 and -9 are both considered as the main enzymes that degrade collagen type-IV (coll-IV), which represents the key collagenous component of ECM and constitutes the architectural structure of vessels and glomerular BM. here is growing evidence implicating MMPs in atherosclerosis as well as in cardiovascular disease (CVD) and chronic kidney disease (CKD). Specific endogenous tissue inhibitors of MMPs (TIMPs) are also implicated in CKD, CVD and diabetic nephropathy (DN).

Conclusion: The present review discusses the role of MMPs -2 and -9 in DN, as a leading cause of endstage renal disease and as a model of the link between progressive glomerulosclerosis and MMP expression.

Keywords: Matrix metalloproteinases, gelatinases, diabetic nephropathy, atherosclerosis, proteinuria, glomerulosclerosis.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Page: [557 - 565]
Pages: 9
DOI: 10.2174/1570161115666170202162345
Price: $65

Article Metrics

PDF: 26
PRC: 1